Study Reveals Gender Patterns of Iron Deficiency in Chronic Kidney Disease

Understanding Iron Deficiency and Hemoglobin

A recent study published in PLoS ONE underscores the significant prevalence of iron deficiency in patients with non-dialysis chronic kidney disease (CKD), alongside notable gender patterns. Hemoglobin, a protein within red blood cells, plays a critical role in transporting oxygen from the lungs to the body’s cells. This essential protein is formed by the combination of heme and iron, with approximately 70% of the body’s iron found in hemoglobin.

To facilitate cellular respiration, iron is stored in the body as ferritin. When blood ferritin levels drop below normal—12-14 gm/dL in women and 14-16 gm/dL in men—it indicates diminished iron stores, leading to a diagnosis of iron deficiency or anemia. Although mild anemia may not present noticeable symptoms, significantly low ferritin levels or a rapid decline can result in fatigue, weakness, shortness of breath, elevated heart rate, and headaches.

Identifying the Cause of Anemia

Upon detecting anemia, it is crucial to identify the underlying cause of the low red blood cell count. This could stem from either inadequate red blood cell production or loss due to bleeding.

Iron Deficiency in Chronic Kidney Disease Patients

Primary Causes of Iron Deficiency

In patients with CKD, the predominant cause of iron deficiency is often linked to difficulties in red blood cell production. Erythropoietin, a substance produced by the kidneys, is essential for stimulating bone marrow to generate red blood cells. Individuals with kidney disease frequently exhibit low erythropoietin levels, leading physicians to prescribe erythropoietin-stimulating agents (ESAs).

Research Overview

The study conducted by researchers in Beirut, Lebanon, explored iron deficiency patterns in non-dialysis CKD patients receiving ESA therapy. This national observational study analyzed data from all non-dialysis CKD patients who applied for ESA treatment during a five-month window from July to November 2016. Patients under 18 years or those who had undergone kidney transplants, as well as those with missing blood ferritin values, were excluded from the study.

Findings on Gender-Specific Iron Deficiency

The research revealed a significant finding: most female patients presented with iron deficiency in the early stages of CKD but showed improvement in iron levels as the disease progressed. One hypothesis suggests that women may not have received adequate medical follow-up, leading to iron deficiency at CKD diagnosis, which was later addressed during follow-up care. In contrast, men exhibited increased iron deficiency as they advanced from CKD stage 3 to stages 4 and 5, likely due to initial adequate iron levels and minimal supplementation during ESA treatment.

This study marks the first national investigation illustrating the divergent progression of iron deficiency between genders throughout CKD advancement. However, a limitation exists due to the lack of comprehensive data regarding prior and current patient treatments, specifically regarding ESA dosage and iron intake. Despite this, the study highlights the insufficient treatment of anemia in CKD patients, as many were screened for iron deficiency for the first time.

Conclusion

In summary, the study emphasizes the importance of monitoring and addressing iron deficiency in CKD patients, with particular attention to gender differences in disease progression and treatment needs.

References

(1) Aoun M, Karam R, Sleilaty G, Antoun L, Ammar W (2018) Iron deficiency across chronic kidney disease stages: Is there a reverse gender pattern? PLoS ONE 13(1): e0191541. https://doi.org/10.1371/journal.pone.0191541
(2) https://www.medicinenet.com/hemoglobin/article.htm